Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

(2016) J R Passweg et al.   BONE MARROW TRANSPLANTATION

How do we mobilize and collect autologous peripheral blood stem cells?

(2016) Shan Yuan et al.   TRANSFUSION

Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean

(2015) A Olivieri et al.   BONE MARROW TRANSPLANTATION

Effectiveness of an Algorithm-Based Approach to the Utilization of Plerixafor in Patients Undergoing Chemotherapy-Based Stem Cell Mobilization

(2014) Eric Chow et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

(2014) M Mohty et al.   BONE MARROW TRANSPLANTATION

Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

(2013) Sergio Giralt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Plerixafor ‘on demand’: results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF

(2013) L Farina et al.   BONE MARROW TRANSPLANTATION

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs

(2013) Giuseppe Milone et al.   BRITISH JOURNAL OF HAEMATOLOGY

Peripheral Blood CD34+ Cell Enumeration as a Predictor of Apheresis Yield: An Analysis of More Than 1,000 Collections

(2012) Peter Gambell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization

(2012) Ivana N.M. Micallef et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization.

(2012) Juan-Manuel Sancho et al.   CYTOTHERAPY

Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma

(2011) Immacolata Attolico et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration

(2011) M E Horwitz et al.   BONE MARROW TRANSPLANTATION

A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

(2011) S Abhyankar et al.   BONE MARROW TRANSPLANTATION

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization

(2011) K Hübel et al.   BONE MARROW TRANSPLANTATION

Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo

(2011) A Olivieri et al.   BONE MARROW TRANSPLANTATION

Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies

(2011) S Sinha et al.   LEUKEMIA

Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process

(2011) Luca Pierelli et al.   TRANSFUSION

Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization

(2010) L J Costa et al.   BONE MARROW TRANSPLANTATION

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

(2009) S Giralt et al.   LEUKEMIA

Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions

(2009) Paolo Perseghin et al.   TRANSFUSION AND APHERESIS SCIENCE

Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation

(2008) Iskra Pusic et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

McNemar χ2test revisited: comparing sensitivity and specificity of diagnostic examinations

(2008) A. Trajman et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD